Jon Oskarsson

Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study

An Overview of the Recent Advances in Antimicrobial Resistance

Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir–Rilpivirine in People With HIV Who Are Virally Unsuppressed

First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic